Business

Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Thomas J. Appio, Chief Executive Officer, and Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the RBC Capital Markets 2026 Global Healthcare Conference in New York City on Wednesday, May 20, 2026. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.

articleBausch Health Companies Inc.May 13, 20262/company/bausch-health-companies-inc/news/bausch-health-to-participate-in-rbc-capital-markets-2026-global-healthcare-conference
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference

About this update from Bausch Health Companies Inc.

[{"type":"text","content":"LAVAL, QC, May 13, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Thomas J. Appio, Chief Executive Officer, and Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the RBC Capital Markets 2026 Global Healthcare Conference in New York City on Wednesday, May 20, 2026. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.","length":492,"tagName":"p"},{"type":"text","content":"Details","length":7,"tagName":"p"},{"type":"text","content":"Date: Wednesday, May 20, 2026","length":29,"tagName":"p"},{"type":"text","content":"Time: 9:30 a.m. U.S. ET","length":23,"tagName":"p"},{"type":"text","content":"Webcast: http://ir.bauschhealth.com/events-and-presentations","length":60,"tagName":"p"},{"type":"text","content":"A replay of the event will be available on the investor relations website following the event.","length":94,"tagName":"p"},{"type":"text","content":"About Bausch Health Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.","length":703,"tagName":"p"},{"type":"text","content":"Forward-looking Statements This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or simi...

More updates from Bausch Health Companies Inc.

Bausch Health Companies Inc.RBC Capital MarketsGlobal Healthcare ConferenceForward-looking Statements